Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding change in Registered Office of the company.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has informed the stock exchanges that its Board has approved shifting the registered office within New Delhi city limits, effective June 02, 2025. The new address is Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020, moved from the previous address at T-210 J, Shahpur Jat, New Delhi-110049. The decision was taken through a circular resolution by the Board of Directors. The disclosure was made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
This is a routine administrative change with no material impact on the company's operations, financials, or shareholders. The move is within the same city, so there is no change in jurisdiction. Investors should not expect any meaningful stock price movement from this announcement.